Microarrays and microneedle arrays for delivery of peptides, proteins, vaccines and other applications

Expert Opinion on Drug Delivery

Volumn 10, Issue 8, 2013, Pages 1155-1170

  Chandrasekhar, Saradha ^a   Iyer, Lavanya K ^a   Panchal, Jainik P ^a   Topp, Elizabeth M ^a   Cannon, John B ^b   Ranade, Vasant V ^c,d  

^a PURDUE UNIVERSITY   (United States)

^b Targeted Drug Solutions   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d Department of Pharmacology ^*  (United States)

Author keywords

Drug targeting; Microarray technologies; Microneedles; Peptide and protein delivery; Vaccines

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; CARBOHYDRATE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERYTHROPOIETIN; HUMAN GROWTH HORMONE; INFLUENZA VACCINE; MICRORNA; NALOXONE; NALTREXONE; PEPTIDE; PHOSPHOTYROSINE; PROTEIN; PROTEIN KINASE; SALCATONIN; SILICON; SMALLPOX VACCINE; TETANUS TOXOID; TRANSCRIPTION FACTOR; TUMOR MARKER; VACCINE; YELLOW FEVER VACCINE;

CANCER GROWTH; DNA METHYLATION; DRUG DELIVERY SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; MICROARRAY ANALYSIS; MICRONEEDLE; NONHUMAN; PROGNOSIS; PROSTATE CANCER; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVIEW; TRANSDERMAL DRUG ADMINISTRATION;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; MICROARRAY ANALYSIS; PEPTIDES; PHARMACEUTICAL PREPARATIONS; PROTEIN ARRAY ANALYSIS; PROTEINS; VACCINES;

EID: 84880521725     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2013.797405     Document Type: Review

References (147)

1. MacBeath G, Schreiber SL. Printing proteins as microarrays for high-throughput function determination. Science 2000;289(5485):1760-3 . This review provides studies on printing proteins as microarrays.
2. Berrade L, Garcia AE, Camarero JA. Protein microarrays: novel developments and applications. Pharm Res 2011;28(7):1480-99 . This article provides comprehensive review of unique developments of protein microarrays.
3. Winkler DF, Campbell WD. The spot technique: synthesis and screening of peptide macroarrays on cellulose membranes. Methods Mol Biol 2008;494:47-70 . A good review on the spot technique used in microarrays.
4. Clark J, Shevchuk T, Swiderski PM, et al. Construction of ordered protein arrays. Methods Mol Biol 2005;300:325-48
5. He M, Stoevesandt O, Taussig MJ. In situ synthesis of protein arrays. Curr Opin Biotechnol 2008;19(1):4-9
6. Angenendt P, Kreutzberger J, Glokler J, et al. Generation of high density protein microarrays by cell-free in situ expression of unpurified PCR products. Mol Cell Proteomics 2006;5(9):1658-66 . A good review regarding methods for fabrication of micromoulding of microneedle arrays. (Pubitemid 44480393)
7. Donnelly RF, Majithiya R, Singh TR, et al. Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique. Pharm Res 2011;28(1):41-57 . This article provides good review regarding dissecting and signaling aspects using protein microarrays, comparing the strength and technical challenges.
8. Wolf-Yadlin A, Sevecka M, MacBeath G. Dissecting protein function and signaling using protein microarrays. Curr Opin Chem Biol 2009;13(4):398-405
9. Hall DA, Ptacek J, Snyder M. Protein microarray technology. Mech Ageing Dev 2007;128(1):161-7 (Pubitemid 46073070)
10. Hall DA, Zhu H, Zhu X, et al. Regulation of gene expression by a metabolic enzyme. Science 2004;306(5695):482-4 (Pubitemid 39372447)
11. Phizicky E, Bastiaens PI, Zhu H, et al. Protein analysis on a proteomic scale. Nature 2003;422(6928):208-15 (Pubitemid 36362758)
12. Zhu H, Bilgin M, Bangham R, et al. Global analysis of protein activities using proteome chips. Science 2001;293(5537):2101-5 (Pubitemid 32848060)
13. Espejo A, Cote J, Bednarek A, et al. A protein-domain microarray identifies novel protein-protein interactions. Biochem J 2002;367(Pt 3):697-702 (Pubitemid 35305708)
14. Blackburn JM, Hart DJ. Fabrication of protein function microarrays for systems-oriented proteomic analysis. Methods Mol Biol 2005;310:197-216
15. Blackburn JM, Shoko A, Beeton-Kempen N. Miniaturized, microarray-based assays for chemical proteomic studies of protein function. Methods Mol Biol 2012;800:133-62
16. MacBeath G, Koehler AN, Schreiber SL. Printing small molecules as microarrays and detecting protein-ligand interactions en masse. J Am Chem Soc 1999;121(34):7967-8 (Pubitemid 29420532)
17. Popescu SC, Popescu GV, Bachan S, et al. MAPK target networks in Arabidopsis thaliana revealed using functional protein microarrays. Genes Dev 2009;23(1):80-92
18. Newman JR, Keating AE. Comprehensive identification of human bZIP interactions with coiled-coil arrays. Science 2003;300(5628):2097-101 (Pubitemid 36760137)
19. Boutell JM, Hart DJ, Godber BL, et al. Functional protein microarrays for parallel characterisation of p53 mutants. Proteomics 2004;4(7):1950-8 (Pubitemid 38880359)
20. Funeriu DP, Eppinger J, Denizot L, et al. Enzyme family-specific and activity-based screening of chemical libraries using enzyme microarrays. Nat Biotechnol 2005;23(5):622-7 (Pubitemid 41724903)
21. Zhu H, Klemic JF, Chang S, et al. Analysis of yeast protein kinases using protein chips. Nat Genet 2000;26(3):283-9
22. Huang J, Zhu H, Haggarty SJ, et al. Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chips. Proc Natl Acad Sci USA 2004;101(47):16594-9 (Pubitemid 39557758)
23. Jung SO, Ro HS, Kho BH, et al. Surface plasmon resonance imaging-based protein arrays for high-throughput screening of protein-protein interaction inhibitors. Proteomics 2005;5(17):4427-31 (Pubitemid 41739920)
24. Jones RB, Gordus A, Krall JA, et al. A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 2006;439(7073):168-74 (Pubitemid 43083134)
25. Gelperin DM, White MA, Wilkinson ML, et al. Biochemical and genetic analysis of the yeast proteome with a movable ORF collection. Genes Dev 2005;19(23):2816-26 (Pubitemid 41739967)
26. Cahill DJ. Protein and antibody arrays and their medical applications. J Immunol Methods 2001;250(1-2):81-91 (Pubitemid 32209243)
27. Katz C, Benyamini H, Rotem S, et al. Molecular basis of the interaction between the antiapoptotic Bcl-2 family proteins and the proapoptotic protein ASPP2. Proc Natl Acad Sci USA 2008;105(34):12277-82
28. Boisguerin P, Leben R, Ay B, et al. An improved method for the synthesis of cellulose membrane-bound peptides with free C termini is useful for PDZ domain binding studies. Chem Biol 2004;11(4):449-59 (Pubitemid 38503579)
29. Merbl Y, Kirschner MW. Large-scale detection of ubiquitination substrates using cell extracts and protein microarrays. Proc Natl Acad Sci USA 2009;106(8):2543-8
30. Haab BB. Advances in protein microarray technology for protein expression and interaction profiling. Curr Opin Drug Discov Devel 2001;4(1):116-23 (Pubitemid 32118467)
31. Janes KA, Albeck JG, Gaudet S, et al. A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis. Science 2005;310(5754):1646-53 (Pubitemid 41780781)
32. Gaudet S, Janes KA, Albeck JG, et al. A compendium of signals and responses triggered by prodeath and prosurvival cytokines. Mol Cell Proteomics 2005;4(10):1569-90 (Pubitemid 41555481)
33. Kusnezow W, Jacob A, Walijew A, et al. Antibody microarrays: an evaluation of production parameters. Proteomics 2003;3(3):254-64 (Pubitemid 36343681)
34. Kusnezow W, Banzon V, Schroder C, et al. Antibody microarray-based profiling of complex specimens: systematic evaluation of labeling strategies. Proteomics 2007;7(11):1786-99 (Pubitemid 46910999)
35. Chen JR, Chang BH, Allen JE, et al. Predicting PDZ domain-peptide interactions from primary sequences. Nat Biotechnol 2008;26(9):1041-5
36. Ng JK, Ajikumar PK, Tang YC, et al. Spatially addressable protein array: ssDNA-directed assembly for antibody microarray. Electrophoresis 2007;28(24):4638-44
37. Boyd ZS, Wu QJ, O'Brien C, et al. Proteomic analysis of breast cancer molecular subtypes and biomarkers of response to targeted kinase inhibitors using reverse-phase protein microarrays. Mol Cancer Ther 2008;7(12):3695-706
38. Chan SM, Ermann J, Su L, et al. Protein microarrays for multiplex analysis of signal transduction pathways. Nat Med 2004;10(12):1390-6 (Pubitemid 40022723)
39. Paweletz CP, Charboneau L, Bichsel VE, et al. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 2001;20(16):1981-9 (Pubitemid 32458030)
40. Sevecka M, MacBeath G. State-based discovery: a multidimensional screen for small-molecule modulators of EGF signaling. Nat Methods 2006;3(10):825-31 . This article provides complimentary information on application of protein microarray technology. (Pubitemid 44445830)
41. Tao SC, Chen CS, Zhu H. Applications of protein microarray technology. Comb Chem High Throughput Screen 2007;10(8):706-18 . This article provides good review on construction of ordered proteins. (Pubitemid 350099315)
42. Sreekumar A, Nyati MK, Varambally S, et al. Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. Cancer Res 2001;61(20):7585-93 (Pubitemid 32995052)
43. Soen Y, Chen DS, Kraft DL, et al. Detection and characterization of cellular immune responses using peptide-MHC microarrays. PLoS Biol 2003;1(3):E65
44. Chen JR, Chang BH, Allen JE, et al. Predicting PDZ domain-peptide interactions from primary sequences. Nat Biotechnol 2008;26(9):1041-5
45. Kuschel C, Steuer H, Maurer AN, et al. Cell adhesion profiling using extracellular matrix protein microarrays. Biotechniques 2006;40(4):523-31 (Pubitemid 46534933)
46. Hsu KL, Pilobello KT, Mahal LK. Analyzing the dynamic bacterial glycome with a lectin microarray approach. Nat Chem Biol 2006;2(3):153-7 (Pubitemid 44323867)
47. Nishizuka S, Charboneau L, Young L, et al. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci USA 2003;100(24):14229-34 (Pubitemid 37499219)
48. Angenendt P, Glokler J, Murphy D, et al. Toward optimized antibody microarrays: a comparison of current microarray support materials. Anal Biochem 2002;309(2):253-60 (Pubitemid 35387317)
49. Braun P, Hu Y, Shen B, et al. Proteome-scale purification of human proteins from bacteria. Proc Natl Acad Sci USA 2002;99(5):2654-9 (Pubitemid 34240516)
50. Ramachandran N, Hainsworth E, Bhullar B, et al. Self-assembling protein microarrays. Science 2004;305(5680):86-90 (Pubitemid 38869377)
51. Giannakis E, Hung L-W, Camacaro KP, et al. Analysis of a beta interactions using proteinchip technology. Methods in molecular biology. Humana Press, Inc; 999 Riverview Dr, Ste 208, Totowa, Nj 07512-1165 USA: 2008. p. 71-86
52. Lebrecht A, Boehm D, Schmidt M, et al. Surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry to detect breast cancer markers in tears and serum. Cancer Genomics Proteomics 2009;6(2):75-83
53. Albrethsen J, Bogebo R, Gammeltoft S, et al. Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study. BMC Cancer 2005;5:8
54. Kozak KR, Su F, Whitelegge JP, et al. Characterization of serum biomarkers for detection of early stage ovarian cancer. Proteomics 2005;5(17):4589-96 (Pubitemid 41739936)
55. Herman D. Keep it simple: microarray cross-platform comparison without statistics. Progress in Inflammation Research. Birkhauser Verlag Ag; Viadukstrasse 40-44, Po Box 133, Ch-4010 Basel, Switzerland: 2008. p. 179-98
56. Canales RD, Luo Y, Willey JC, et al. Evaluation of DNA microarray results with quantitative gene expression platforms. Nat Biotechnol 2006;24(9):1115-22 (Pubitemid 44359723)
57. Bosio A. Microarray and inflammation: an introduction. Progress in inflammation research. Birkhauser Verlag Ag; Viadukstrasse 40-44, Po Box 133, Ch-4010 Basel, Switzerland: 2008. p. 1-11
58. Gerstmayer B. Complementary microarray technologies: Microarrays in Inflammation. In: Bosio A, Gerstmayer B, editors. Birkhäuser; Basel: 2008. p. 213-24
59. Duggan DJ, Bittner M, Chen Y, et al. Expression profiling using cDNA microarrays. Nat Genet 1999;21(1 Suppl):10-14 (Pubitemid 29031485)
60. Leung YF, Cavalieri D. Fundamentals of cDNA microarray data analysis. Trends Genet 2003;19(11):649-59 (Pubitemid 37338385)
61. Bumgarner R. Overview of DNA microarrays: types, applications, and their future. Curr Protoc Mol Biol 2013;Chapter 22:Unit 22 1
62. Keren B, Le Caignec C. Oligonucleotide microarrays in constitutional genetic diagnosis. Expert Rev Mol Diagn 2011;11(5):521-32
63. de Leeuw N, Hehir-Kwa JY, Simons A, et al. SNP array analysis in constitutional and cancer genome diagnostics-copy number variants, genotyping and quality control. Cytogenet Genome Res 2011;135(3-4):212-21
64. Kaushansky A, Allen JE, Gordus A, et al. Quantifying protein-protein interactions in high throughput using protein domain microarrays. Nat Protoc 2010;5(4):773-90
65. Sanchez-Carbayo M, Socci ND, Lozano JJ, et al. Profiling bladder cancer using targeted antibody arrays. Am J Pathol 2006;168(1):93-103 (Pubitemid 43062562)
66. Sokolov BP, Cadet JL. Methamphetamine causes alterations in the MAP kinase-related pathways in the brains of mice that display increased aggressiveness. Neuropsychopharmacology 2006;31(5):956-66
67. Kiat NJ, Simeon F, Phon TH, et al. DNA-directed assembly microarray for protein and small molecule inhibitor screening. Methods Mol Biol 2011;716:127-40
68. Lin YY, Lu JY, Zhang J, et al. Protein acetylation microarray reveals that NuA4 controls key metabolic target regulating gluconeogenesis. Cell 2009;136(6):1073-84
69. Spisak S, Guttman A. Biomedical applications of protein microarrays. Curr Med Chem 2009;16(22):2806-15
70. Gong W, He K, Covington M, et al. The development of protein microarrays and their applications in DNA-protein and protein-protein interaction analyses of Arabidopsis transcription factors. Mol Plant 2008;1(1):27-41
71. Anderson KS, Ramachandran N, Wong J, et al. Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer. J Proteome Res 2008;7(4):1490-9
72. Hudson ME, Pozdnyakova I, Haines K, et al. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc Natl Acad Sci USA 2007;104(44):17494-9 (Pubitemid 350219866)
73. Ajikumar PK, Ng JK, Tang YC, et al. Carboxyl-terminated dendrimer-coated bioactive interface for protein microarray: high-sensitivity detection of antigen in complex biological samples. Langmuir 2007;23(10):5670-7 (Pubitemid 46826521)
74. Gail R, Frank R, Wittinghofer A. Systematic peptide array-based delineation of the differential beta-catenin interaction with Tcf4, E-cadherin, and adenomatous polyposis coli. J Biol Chem 2005;280(8):7107-17 (Pubitemid 40341267)
75. Lueking A, Huber O, Wirths C, et al. Profiling of alopecia areata autoantigens based on protein microarray technology. Mol Cell Proteomics 2005;4(9):1382-90 (Pubitemid 41448724)
76. Clark J, Shevchuk T, Swiderski PM, et al. Construction of ordered protein arrays. Methods Mol Biol 2005;300:325-48
77. Fujita S, Onuki-Nagasaki R, Fukuda J, et al. Development of super-dense transfected cell microarrays generated by piezoelectric inkjet printing. Lab Chip 2013;13(1):77-80
78. Zarowna-Dabrowska A, McKenna EO, Schutte ME, et al. Generation of primary hepatocyte microarrays by piezoelectric printing. Colloids Surf B Biointerfaces 2012;89:126-32
79. Malainou A, Petrou PS, Kakabakos SE, et al. Creating highly dense and uniform protein and DNA microarrays through photolithography and plasma modification of glass substrates. Biosens Bioelectron 2012;34(1):273-81
80. Linares AV, Falcimaigne-Cordin A, Gheber LA, et al. Patterning nanostructured, synthetic, polymeric receptors by simultaneous projection photolithography, nanomolding, and molecular imprinting. Small 2011;Epub ahead of print
81. Son KJ, Ahn SH, Kim JH, et al. Graft copolymerlated mesoporous TiO(2) films micropatterned with poly(ethylene glycol) hydrogel: novel platform for highly sensitive protein microarrays. ACS Appl Mater Interfaces 2011;3(2):573-81
82. Choi YS, Lee CS. Generation of protein and cell microarrays on functionalized surfaces. Methods Mol Biol 2011;671:207-17
83. Koh WG. Cell microarrays based on hydrogel microstructures for the application to cell-based biosensor. Methods Mol Biol 2011;671:133-45
84. Lee JY, Shah SS, Zimmer CC, et al. Use of photolithography to encode cell adhesive domains into protein microarrays. Langmuir 2008;24(5):2232-9 (Pubitemid 351500988)
85. Nuwaysir EF, Huang W, Albert TJ, et al. Gene expression analysis using oligonucleotide arrays produced by maskless photolithography. Genome Res 2002;12(11):1749-55 (Pubitemid 35363679)
86. Gao X, Pellois JP, Na Y, et al. High density peptide microarrays. In situ synthesis and applications. Mol Divers 2004;8(3):177-87 (Pubitemid 39066239)
87. Triche TJ, Schofield D, Buckley J. DNA microarrays in pediatric cancer. Cancer J 2001;7(1):2-15
88. Bariya SH, Gohel MC, Mehta TA, et al. Microneedles: an emerging transdermal drug delivery system. J Pharm Pharmacol 2012;64(1):11-29
89. Peters EE, Ameri M, Wang X, et al. Erythropoietin-coated ZP-microneedle transdermal system: preclinical formulation, stability, and delivery. Pharm Res 2012;29(6):1618-26
90. Garland MJ, Migalska K, Mahmood TM, et al. Microneedle arrays as medical devices for enhanced transdermal drug delivery. Expert Rev Med Devices 2011;8(4):459-82
91. Migalska K, Morrow DI, Garland MJ, et al. Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery. Pharm Res 2011;28(8):1919-30 . A good discussion regarding transdermal delivery using dissolving microneedles.
92. Ito Y, Hagiwara E, Saeki A, et al. Feasibility of microneedles for percutaneous absorption of insulin. Eur J Pharm Sci 2006;29(1):82-8 (Pubitemid 44279397)
93. Ito Y, Hasegawa R, Fukushima K, et al. Self-dissolving micropile array chip as percutaneous delivery system of protein drug. Biol Pharm Bull 2010;33(4):683-90 . This article reports feasibility studies of microneedles and discusses study on the array chip for delivery of protein drug.
94. Zarnitsyn VG, Meacham JM, Varady MJ, et al. Electrosonic ejector microarray for drug and gene delivery. Biomed Microdevices 2008;10(2):299-308
95. Oh BK, Kim YK, Lee W, et al. Immunosensor for detection of Legionella pneumophila using surface plasmon resonance. Biosens Bioelectron 2003;18(5-6):605-11 (Pubitemid 36428649)
96. Kalluri H, Banga AK. Transdermal Delivery of Proteins. AAPS PharmSciTech 2011;12(1):431-41
97. Donnelly RF, Singh TRR, Woolfson AD. Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv 2010;17(4):187-207 . This article provides comprehensive review on the microneedle-based drug delivery systems.
98. Martanto W, Davis SP, Holiday NR, et al. Transdermal delivery of insulin using microneedles in vivo. Pharm Res 2004;21(6):947-52 (Pubitemid 38870143)
99. Kalluri H, Kolli CS, Banga AK. Characterization of Microchannels Created by Metal Microneedles: formation and Closure. Aaps J 2011;13(3):473-81
100. Bhowmik T, D'Souza B, Shashidharamurthy R, et al. A novel microparticulate vaccine for melanoma cancer using transdermal delivery. J Microencapsul 2011;28(4):294-300
101. Li G, Badkar A, Kalluri H, Banga AK. Microchannels created by sugar and metal microneedles: characterization by microscopy, macromolecular flux and other techniques. J Pharm Sci 2010;99(4):1931-41
102. Cormier M, Johnson B, Ameri M, et al. Transdermal delivery of desmopressin using a coated microneedle array patch system. J Control Release 2004;97(3):503-11 (Pubitemid 38802952)
103. Daddona PE, Matriano JA, Mandema J, et al. Parathyroid hormone (1-34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis. Pharm Res 2011;28(1):159-65
104. Saurer EM, Flessner RM, Sullivan SP, et al. Layer-by-layer assembly of dnaand protein-containing films on microneedles for drug delivery to the skin. Biomacromolecules 2010;Epub ahead of print
105. Tas C, Mansoor S, Kalluri H, et al. Delivery of salmon calcitonin using a microneedle patch. Int J Pharm 2012;423(2):257-63
106. Zhang Y, Brown K, Siebenaler K, et al. Development of lidocaine-coated microneedle product for rapid, safe, and prolonged local analgesic action. Pharm Res 2012;29(1):170-7
107. McAllister DV, Wang PM, Davis SP, et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci USA 2003;100(24):13755-60 (Pubitemid 37499139)
108. Daugimont L, Baron N, Vandermeulen G, et al. Hollow microneedle arrays for intradermal drug delivery and DNA electroporation. J Membr Biol 2010;236(1):117-25
109. Smart WH, Subramanian K. The use of silicon microfabrication technology in painless blood glucose monitoring. Diabetes Technol Ther 2000;2:549-59 (Pubitemid 32173118)
110. Gittard SD, Ovsianikov A, Chichkov BN, et al. Two-photon polymerization of microneedles for transdermal drug delivery. Expert Opin Drug Deliv 2010;7(4):513-33
111. Burton SA, Ng CY, Simmers R, et al. Rapid intradermal delivery of liquid formulations using a hollow microstructured array. Pharm Res 2011;28(1):31-40
112. Coulman S, Allender C, Birchall J. Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy. Crit Rev Ther Drug Carrier Syst 2006;23(3):205-58 (Pubitemid 44950092)
113. Ito Y, Ohashi Y, Saeki A, et al. Antihyperglycemic effect of insulin from self-dissolving micropiles in dogs. Chem Pharm Bull (Tokyo) 2008;56(3):243-6 (Pubitemid 351463230)
114. Ito Y, Ohashi Y, Shiroyama K, et al. Self-dissolving micropiles for the percutaneous absorption of recombinant human growth hormone in rats. Biol Pharm Bull 2008;31(8):1631-3
115. Ito Y, Yoshimitsu J, Shiroyama K, et al. Self-dissolving microneedles for the percutaneous absorption of EPO in mice. J Drug Target 2006;14(5):255-61 (Pubitemid 44173291)
116. Fukushima K, Ise A, Morita H, et al. Two-layered dissolving microneedles for percutaneous delivery of peptide/protein drugs in rats. Pharm Res 2011;28(1):7-21
117. Lee JW, Park JH, Prausnitz MR. Dissolving microneedles for transdermal drug delivery. Biomaterials 2008;29(13):2113-24
118. Ito Y, Ise A, Sugioka N, et al. Molecular weight dependence on bioavailability of FITC-dextran after administration of self-dissolving micropile to rat skin. Drug Dev Ind Pharm 2010;36(7):845-51
119. Baek C, Han M, Min J, et al. Local transdermal delivery of phenylephrine to the anal sphincter muscle using microneedles. J Control Release 2011;154(2):138-47
120. Li G, Badkar A, Nema S, et al. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles. Int J Pharm 2009;368(1-2):109-15
121. Wendorf JR, Ghartey-Tagoe EB, Williams SC, et al. Transdermal delivery of macromolecules using solid-state biodegradable microstructures. Pharm Res 2011;28(1):22-30
122. Wonglertnirant N, Todo H, Opanasopit P, et al. Macromolecular delivery into skin using a hollow microneedle. Biol Pharm Bull 2010;33(12):1988-93
123. Milewski M, Yerramreddy TR, Ghosh P, et al. In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin. J Control Release 2010;146(1):37-44
124. Wang PM, Cornwell M, Hill J, et al. Precise microinjection into skin using hollow microneedles. J Invest Dermatol 2006;126(5):1080-7
125. Banks SL, Pinninti RR, Gill HS, et al. Flux across [corrected] microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro. Pharm Res 2008;25(7):1677-85
126. Olatunji O, Das DB, Nassehi V. Modelling transdermal drug delivery using microneedles: effect of geometry on drug transport behaviour. J Pharm Sci 2012;101(1):164-75
127. Al-Qallaf B, Das DB, Mori D, et al. Modelling transdermal delivery of high molecular weight drugs from microneedle systems. Philos Transact A Math Phys Eng Sci 2007;365(1861):2951-67
128. Davidson A, Al-Qallaf B, Das DB. Transdermal drug delivery by coated microneedles: geometry effects on effective skin thickness and drug permeability. Chem Eng Res Des 2008;86(11):1196-206
129. Al-Qallaf B, Das DB. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery. Ann NY Acad Sci 2009;1161(1):83-94
130. Al-Qallaf B, Das DB, Mori D, Cui Z. Modelling transdermal delivery of high molecular weight drugs from microneedle systems. Philos Transact A Math Phys Eng Sci 2007;365(1861):2951-67
131. Yoon J, Park D, Son T, et al. A physical method to enhance transdermal delivery of a tissue optical clearing agent: combination of microneedling and sonophoresis. Lasers Surg Med 2010;42(5):412-17
132. Garland MJ, Caffarel-Salvador E, Migalska K, et al. Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery. J Control Release 2012;159(1):52-9
133. Katikaneni S, Li G, Badkar A, Banga AK. Transdermal delivery of a approximately 13 kDa protein-an in vivo comparison of physical enhancement methods. J Drug Target 2010;18(2):141-7
134. Udey MC. Skin dendritic cells in immunity and autoimmunity. J Investig Dermatol Symp Proc 2004;9(1):15-17 (Pubitemid 38096192)
135. La Montagne JR, Fauci AS. Intradermal influenza vaccination-can less be more N Engl J Med 2004;351(22):2330-2 (Pubitemid 39552751)
136. Kis EE, Winter G, Myschik J. Devices for intradermal vaccination. Vaccine 2012;30(3):523-38
137. Prausnitz MR, Mikszta JA, Cormier M, et al. Microneedle-based vaccines. Curr Top Microbiol Immunol 2009;333:369-93
138. Mikszta JA, Dekker JP III, Harvey NG, et al. Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine. Infect Immun 2006;74(12):6806-10 (Pubitemid 44913155)
139. Koutsonanos DG, del Pilar Martin M, Zarnitsyn VG, et al. Transdermal influenza immunization with vaccine-coated microneedle arrays. PLoS One 2009;4(3):e4773
140. Zhu Q, Zarnitsyn VG, Ye L, et al. Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge. Proc Natl Acad Sci USA 2009;106(19):7968-73
141. Hooper JW, Golden JW, Ferro AM, et al. Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge. Vaccine 2007;25(10):1814-23 (Pubitemid 46176327)
142. Dean CH, Alarcon JB, Waterston AM, et al. Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates. Hum Vaccin 2005;1(3):106-11
143. Kumar A, Li X, Sandoval MA, et al. Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin. Int J Nanomedicine 2011;6:1253-64
144. Gill HS, Soderholm J, Prausnitz MR, et al. Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine. Gene Ther 2010;17(6):811-14
145. Froetschl R, Kasper P. Microarrays in drug development: regulatory perspective. Progress in inflammation research. Birkhauser Verlag Ag; Viadukstrasse 40-44, Po Box 133, Ch-4010 Basel, Switzerland: 2008. p. 199. 209
146. Häupl T, Grützkau A, Stuhlmüller B, et al. The genes behind rheumatology. In: Bosio A, Gerstmayer B, editors. Microarrays in inflammation. Birkhäuser; Basel: 2008. p. 145-60
147. Baranzini SE. Gene expression profiling in neurological and neuroinflammatory diseases. Progress in inflammation research. Birkhauser Verlag Ag; Viadukstrasse 40-44, Po Box 133, Ch-4010 Basel, Switzerland: 2008. p. 115-30